Der deutsche Bundesrat hat 2015 die Entlassung der Notfallkontrazeptiva aus der Verschreibungspflicht beschlossen. Beobachtungen aus anderen europäischen Ländern sowie erste Daten aus Deutschland zeigen, dass sich trotz dieser Liberalisierung der Abgabe bislang die Rate ungewollter Schwangerschaften nicht verringern ließ. Um dieses Ziel zu erreichen, ist weiterhin eine adäquate Aufklärungsarbeit auf verschiedenen Ebenen unerlässlich.
Literatur
Wilcox, A.J., C.R. Weinberg, and D.D. Baird, Post-ovulatory ageing of the human oocyte and embryo failure. Hum Reprod, 1998. 13(2): p. 394–7.
Group, E.C., Emergency contraception. Widely available and effective but disappointing as a public health intervention: a review. Hum Reprod, 2015. 30(4): p. 751–60.
Cheng, L., Y. Che, and A.M. Gulmezoglu, Interventions for emergency contraception. Cochrane Database Syst Rev, 2012(8): p. CD001324.
Brache, V., et al., Immediate pre-ovulatory administration of 30 mg ulipristal acetate significantly delays follicular rupture. Hum Reprod, 2010. 25(9): p. 2256–63.
Novikova, N., et al., Effectiveness of levonorgestrel emergency contraception given before or after ovulation — a pilot study. Contraception, 2007. 75(2): p. 112–8.
Brache, V., et al., Ulipristal acetate prevents ovulation more effectively than levonorgestrel: analysis of pooled data from three randomized trials of emergency contraception regimens. Contraception, 2013. 88(5): p. 611–8.
Gemzell-Danielsson, K., C. Berger, and P.G. Lalitkumar, Mechanisms of action of oral emergency contraception. Gynecol Endocrinol, 2014. 30(10): p. 685–7.
Gemzell-Danielsson, K., C. Berger, and G.L.L. P, Emergency contraception — mechanisms of action. Contraception, 2013. 87(3): p. 300–8.
Noe, G., et al., Contraceptive efficacy of emergency contraception with levonorgestrel given before or after ovulation. Contraception, 2011. 84(5): p. 486–92.
Glasier, A.F., et al., Ulipristal acetate versus levonorgestrel for emergency contraception: a randomised non-inferiority trial and meta-analysis. Lancet, 2010. 375(9714): p. 555–62.
Kiechle, M. and M. Neuenfeldt, Experience with oral emergency contraception since the OTC switch in Germany. Arch Gynecol Obstet, 2017. 295(3): p. 651–660.
Polis, C.B., et al., Advance provision of emergency contraception for pregnancy prevention: a meta-analysis. Obstet Gynecol, 2007. 110(6): p. 1379–88.
Rodriguez, M.I., et al., Advance supply of emergency contraception: a systematic review. Contraception, 2013. 87(5): p. 590–601.
Lakha, F. and A. Glasier, Unintended pregnancy and use of emergency contraception among a large cohort of women attending for antenatal care or abortion in Scotland. Lancet, 2006. 368(9549): p. 1782–7.
Sorensen, M.B., B.L. Pedersen, and L.E. Nyrnberg, Differences between users and non-users of emergency contraception after a recognized unprotected intercourse. Contraception, 2000. 62(1): p. 1–3.
Cameron, S.T., R. Gordon, and A. Glasier, The effect on use of making emergency contraception available free of charge. Contraception, 2012. 86(4): p. 366–9.
Westley, E., et al., A review of global access to emergency contraception. Int J Gynaecol Obstet, 2013. 123(1): p. 4–6.
von Rosen, F.T., et al., Awareness and knowledge regarding emergency contraception in Berlin adolescents. Eur J Contracept Reprod Health Care, 2017. 22(1): p. 45–52.
Practice Bulletin Summary No. 152: Emergency Contraception. Obstet Gynecol, 2015. 126(3): p. 685-6.
Dragoman, M.V., et al., Research gaps identified during the 2014 update of the WHO medical eligibility criteria for contraceptive use and selected practice recommendations for contraceptive use. Contraception, 2016. 94(3): p. 195–201.
Cameron, S.T., et al., The effects on ovarian activity of ulipristal acetate when ‚quickstarting‘ a combined oral contraceptive pill: a prospective, randomized, double-blind parallel-arm, placebo-controlled study. Hum Reprod, 2015. 30(7): p. 1566–72.
Brache, V., et al., A prospective, randomized, pharmacodynamic study of quick-starting a desogestrel progestin-only pill following ulipristal acetate for emergency contraception. Hum Reprod, 2015. 30(12): p. 2785–93.
Black, A., et al., Canadian Contraception Consensus (Part 2 of 4). J Obstet Gynaecol Can, 2015. 37(11): p. 1033–9.
Michie, L., et al., Contraceptive use among women presenting to pharmacies for emergency contraception: an opportunity for intervention. J Fam Plann Reprod Health Care, 2014. 40(3): p. 190–5.
Michie, L., et al., Pharmacy-based interventions for initiating effective contraception following the use of emergency contraception: a pilot study. Contraception, 2014. 90(4): p. 447–53.
Glasier, A., et al., Community pharmacists providing emergency contraception give little advice about future contraceptive use: a mystery shopper study. Contraception, 2010. 82(6): p. 538–42.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Segerer, S. Notfallkontrazeptiva — Bilanz nach Wegfall der Verschreibungspflicht. gynäkologie + geburtshilfe 22, 34–38 (2017). https://doi.org/10.1007/s15013-017-1282-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s15013-017-1282-0